The Viral And Non-Viral Vector Manufacturing Global Market Report 2023, provides comprehensive information on the viral and non-viral vector manufacturing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Viral And Non-Viral Vector Manufacturing Market’s Growth:
As per The Business Research Company’s Viral And Non-Viral Vector Manufacturing Global Market Report 2023, the global viral and non-viral vector manufacturing market is expected to grow from $6 billion in 2022 to $7.22 billion in 2023 at a compound annual growth rate (CAGR) of 20.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The viral and non-viral vector manufacturing market is expected to reach $14.71 billion in 2027 at a CAGR of 19.5%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12570&type=smp
Technological advancements are a key trend gaining popularity in the viral and non-viral vector manufacturing markets. Major companies operating in the viral and non-viral vector manufacturing markets are developing technologically advanced solutions to sustain their position in the market. For instance, in August 2022, Merck KGaA, a Germany-based science and technology company, launched the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. One of the first Contract development and manufacturing organizations and technology creators to offer an entire viral vector manufacturing package, including AAV, Lentiviral, CDMO, CTO, and process development. With the help of this innovative platform, biopharmaceutical businesses may shorten the time and expense of process development while accelerating the time to clinical manufacture.
The viral and non-viral vector manufacturing market is segmented:
1) By Vector Type: Viral Vector, Non-Viral Vector
2) By Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
3) By Application: Gene Therapy, Vaccinology, Cell Therapy, Other Applications
North America was the largest region in the viral and non-viral vector manufacturing market in 2022.
The table of contents in TBRC’s viral and non-viral vector manufacturing market report includes:
- Executive Summary
- Viral And Non-Viral Vector Manufacturing Market Characteristics
- Viral And Non-Viral Vector Manufacturing Market Trends And Strategies
- Viral And Non-Viral Vector Manufacturing Market – Macro Economic Scenario
- Global Viral And Non-Viral Vector Manufacturing Market Size and Growth
.
.
.
- Viral And Non-Viral Vector Manufacturing Market Other Major And Innovative Companies
- Global Viral And Non-Viral Vector Manufacturing Market Competitive Benchmarking
- Global Viral And Non-Viral Vector Manufacturing Market Competitive Dashboard
- Key Mergers And Acquisitions In The Viral And Non-Viral Vector Manufacturing Market
- Viral And Non-Viral Vector Manufacturing Market Future Outlook and Potential Analysis
Top Major Players
- Novartis AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- FUJIFILM Holdings Corporation
- Regeneron Pharmaceuticals Inc.
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
